Paper34452002
Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines.
Saso A and 2 others. Vaccines (Basel), 2021. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines. Papers, record 34452002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34452002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MC_PC_17221 | Medical Research Council | United Kingdom | PubMed | |
| MC_UP_A900_1122 | Medical Research Council | United Kingdom | PubMed | |
| MR/R005974/1 | Medical Research Council | United Kingdom | PubMed | |
| MR/R005990/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References312
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29092906 | Application and utility of mass cytometry in vaccine development. | FASEB J | 2018 | https://conductscience.org/library/papers/29092906 | PubMed |
| 2 | 28623146 | An update of the global burden of pertussis in children younger than 5 years: a modelling study. | Lancet Infect Dis | 2017 | https://conductscience.org/library/papers/28623146 | PubMed |
| 3 | 28289059 | What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing. | Cold Spring Harb Perspect Biol | 2017 | https://conductscience.org/library/papers/28289059 | PubMed |
| 4 | 29531137 | The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs. | Infect Immun | 2018 | https://conductscience.org/library/papers/29531137 | PubMed |
| 5 | 11063487 | New methods for assessing T-cell responses. | Clin Diagn Lab Immunol | 2000 | https://conductscience.org/library/papers/11063487 | PubMed |
| 6 | 28368490 | Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis. | J Infect Dis | 2017 | https://conductscience.org/library/papers/28368490 | PubMed |
| 7 | 25182980 | The baboon model of pertussis: effective use and lessons for pertussis vaccines. | Expert Rev Vaccines | 2014 | https://conductscience.org/library/papers/25182980 | PubMed |
| 8 | 31321755 | How Genomics Is Changing What We Know About the Evolution and Genome of Bordetella pertussis. | Adv Exp Med Biol | 2019 | https://conductscience.org/library/papers/31321755 | PubMed |
| 9 | 28329702 | Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny. | Immunity | 2017 | https://conductscience.org/library/papers/28329702 | PubMed |
| 10 | 29025851 | Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model. | BMJ Open | 2017 | https://conductscience.org/library/papers/29025851 | PubMed |
| 11 | 24785950 | In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. | AIDS | 2014 | https://conductscience.org/library/papers/24785950 | PubMed |
| 12 | 34211481 | Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives. | Front Immunol | 2021 | https://conductscience.org/library/papers/34211481 | PubMed |
| 13 | 28533445 | Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice with Bordetella pertussis. | J Immunol | 2017 | https://conductscience.org/library/papers/28533445 | PubMed |
| 14 | 33335323 | T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. | Nat Med | 2021 | https://conductscience.org/library/papers/33335323 | PubMed |
| 15 | 23187316 | Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. | Mucosal Immunol | 2013 | https://conductscience.org/library/papers/23187316 | PubMed |
| 16 | 10858197 | Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. | Infect Immun | 2000 | https://conductscience.org/library/papers/10858197 | PubMed |
| 17 | 24726248 | Immune response to Bordetella pertussis is associated with season and undernutrition in Senegalese children. | Vaccine | 2014 | https://conductscience.org/library/papers/24726248 | PubMed |
| 18 | 27118638 | Transcriptome signature for dampened Th2 dominance in acellular pertussis vaccine-induced CD4(+) T cell responses through TLR4 ligation. | Sci Rep | 2016 | https://conductscience.org/library/papers/27118638 | PubMed |
| 19 | 23592988 | Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/23592988 | PubMed |
| 20 | 32896653 | Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial. | Clin Microbiol Infect | 2021 | https://conductscience.org/library/papers/32896653 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42188785 | Screening Epitopes Through Comparative Analysis of Children and Mice Immune Responses to Pertussis Toxin Subunits (S1-S5) Induced by Whole-Cell Pertussis Vaccination. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188785 | PubMed |
| 41600951 | Revisiting Whooping Cough: Global Drivers and Implications of Pertussis Resurgence in the Acellular Vaccine Era. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41600951 | PubMed |
| 40731336 | Clinical and immunological predictors of severe pertussis in children: a nomogram-based prediction model. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/40731336 | PubMed |
| 40433465 | Exploiting subtractive genomics to identify novel drug targets and new immunogenic candidates against Bordetella pertussis: an in silico study. | Front Bioinform | 2025 | https://conductscience.org/library/papers/40433465 | PubMed |
| 39272136 | Programming Bordetella pertussis lipid A to promote adjuvanticity. | Microb Cell Fact | 2024 | https://conductscience.org/library/papers/39272136 | PubMed |
| 39037200 | Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions. | Expert Rev Vaccines | 2024 | https://conductscience.org/library/papers/39037200 | PubMed |
| 37490913 | T cell reactivity to Bordetella pertussis is highly diverse regardless of childhood vaccination. | Cell Host Microbe | 2023 | https://conductscience.org/library/papers/37490913 | PubMed |
| 36996148 | Prevalence of SARS-COV-2 and other respiratory pathogens among a Jordanian subpopulation during Delta-to-Omicron transition: Winter 2021/2022. | PLoS One | 2023 | https://conductscience.org/library/papers/36996148 | PubMed |
| 36895562 | Generating enhanced mucosal immunity against Bordetella pertussis: current challenges and new directions. | Front Immunol | 2023 | https://conductscience.org/library/papers/36895562 | PubMed |
| 35677044 | Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries. | Front Immunol | 2022 | https://conductscience.org/library/papers/35677044 | PubMed |
| 35214778 | Modulation of Inflammatory Signaling Molecules in Bordetella pertussis Antigen-Challenged Human Monocytes in Presence of Adrenergic Agonists. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35214778 | PubMed |
| 35103810 | Non-primate animal models for pertussis: back to the drawing board? | Appl Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/35103810 | PubMed |
| 35062708 | Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/35062708 | PubMed |
| 34579251 | Special Issue "Immune Ontogeny and Vaccination in Early Life: How the Non-Human Primate Model Can Help Expand the Current Knowledge in Pediatric Immunology and Infectious Diseases Research". | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34579251 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34452002
GET https://conductscience.org/api/papers/v1/34452002/references?page=2